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Patients’ Information Coping Styles Influence the Benefit of a 
Survivorship Care Plan in the ROGY Care Trial: New Insights for 
Tailored Delivery
Belle H. de Rooij, MSc1,2; Nicole P. M. Ezendam, PhD1,2; M. Caroline Vos, MSc3; Johanna M. A. Pijnenborg, MD, PhD4; 
Dorry Boll, MD, PhD5; Roy F. P. M. Kruitwagen, MD, PhD6; and Lonneke V. van de Poll-Franse, PhD1,2,7
BACKGROUND: In efforts to improve the implementation of survivorship care plans (SCPs), the authors assessed whether the impact 
of SCPs on patient-reported outcomes differed between patients with an information-seeking coping style (monitoring) versus those 
with an information-avoiding coping style (blunting). METHODS: In the Registration System Oncological Gynecology (ROGY) Care 
Trial, 12 hospitals in the Netherlands were randomized to deliver SCP care or usual care. All patients with newly diagnosed endometrial 
and ovarian cancer in the SCP care arm received an SCP that was generated automatically by their oncology provider through the 
web-based ROGY registration system. Outcomes (satisfaction with information provision and care, illness perceptions, and health care 
use) were measured directly after initial treatment and after 6, 12, and 24 months. Information coping style was measured at 12 months 
after initial treatment. RESULTS: Among patients who had a monitoring coping style (N = 123), those in the SCP care arm reported 
higher satisfaction with information provision (mean score: 73.9 vs 63.9, respectively; P = .04) and care (mean score: 74.5 vs 69.2, re-
spectively; P = .03) compared with those in the usual care arm. Among patients who had a blunting coping style (N = 102), those in the 
SCP care arm reported a higher impact of the disease on life (mean score: 5.0 vs 4.5, respectively; P = .02) and a higher emotional 
impact of the disease (mean score: 5.4 vs 4.2, respectively; P = .01) compared with those in the usual care arm. CONCLUSIONS: SCPs 
may be beneficial for patients who desire information about their disease, whereas SCPs may be less beneficial for patients who avoid 
medical information, suggesting a need for tailored SCP delivery to improve survivorship care. Cancer 2019;125:788-797. © 2018 The 
Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the 
terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, 
provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. 
KEYWORDS: coping, gynecologic cancer, illness perception, information provision, patient satisfaction, survivorship care plan.
INTRODUCTION
For more than a decade, survivorship care plans (SCPs) have been broadly endorsed as a means to improve care coordina-
tion and to address unmet information needs in the growing population of cancer survivors.1 Since the first recommen-
dation by the US Institute of Medicine in 2006,1 SCPs have been the focus of survivorship care research.2 Despite these 
efforts, the evidence base for the impact of SCPs among cancer survivors is still inconclusive, and directions for future 
implementation of SCPs remain under debate.3 Randomized controlled trials (RTCs) have failed to identify the benefits 
of SCP delivery on patient satisfaction, quality of life, and distress in various patient populations, including those with 
breast,4,5 gynecologic,6-8 colorectal,9 and prostate10 cancers. However, SCPs may be beneficial for selected subgroups of 
survivors, such as underserved populations11 and patients who do not use other sources of medical information like the 
internet,12 indicating that we should focus on those individuals who benefit most from SCPs.
Ample research in health communication demonstrates that individuals respond differently to medical informa-
tion because of different coping strategies.13,14 Miller identified 2 main information coping styles for dealing with 
health threats like: monitoring and blunting.15 Monitors typically seek for information relevant for them with regard 
to their health threat, whereas blunters prefer to avoid medical information and distract from it. Monitors report more 
anxiety related to their cancer treatment,16 desire more voluminous and detailed information about their disease, and 
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to be dissatisfied more often with the information they 
receive.17 Conversely, excessive information before a di-
agnostic procedure resulted in more self-reported tension, 
depression, and physical discomfort among patients who 
had a blunting coping style.18 Hence, in a sample of gy-
necologic patients at risk of cancer, stress reduction ap-
pears to be most optimal for monitors when they receive 
detailed information, whereas blunters respond better 
when they receive minimal information.19 These find-
ings suggest that SCPs may be more beneficial for cancer 
survivors who have a monitoring coping style compared 
with those who have a blunting coping style.
In efforts to improve the future implementation of 
SCPs, our objective was to determine whether informa-
tion coping style moderates the impact of SCPs on pa-
tient-reported outcomes among patients with gynecologic 
cancer in the pragmatic cluster-randomized Registration 
System Oncological Gynecology (ROGY) Care Trial, in-
cluding satisfaction with information provision and care, 
illness perceptions, and health care use. In the main anal-
yses of that trial, the overall effects of SCPs were assessed 
among patients who had endometrial and ovarian cancer. 
We demonstrated that SCPs did not improve satisfaction 
with information provision and care but, rather, increased 
worry, emotional impact, and experienced symptoms 
among women with endometrial cancer7 and decreased 
trust in the treatment among those with ovarian cancer.8 
However, we hypothesize that SCPs have a positive effect 
on satisfaction with information provision and care and 
on health care use among patients who have a monitoring 
coping style but not among those who have a blunting 
coping style, whereas SCPs may increase threatening ill-
ness perceptions in patients who have a blunting coping 
style but not those who have a monitoring coping style.
MATERIALS AND METHODS
Design
The ROGY Care Trial is a pragmatic, cluster RTC in which 
the objective is to assess the impact of automatically gener-
ated SCPs on patient-reported outcomes among patients with 
endometrial and ovarian cancer during 2 years of follow-up. 
Twelve hospitals in the Netherlands were randomized to de-
liver either SCP care or usual care. The trial was centrally 
approved by a Medical Research Ethics Committee and is 
registered as NCT01185626 on clinicaltrials.gov. Further 
details about the design are described in the trial protocol.20
Participants and Recruitment
After initial treatment, all patients who were newly diag-
nosed with endometrial cancer between April 2011 and 
October 2012 or with ovarian cancer between April 2011 
and March 2014 were invited to participate by their own 
gynecologist with a letter and an informed-consent form. 
After consent, questionnaires were sent to the patients 
after treatment and at 6, 12, and 24 months after treat-
ment. Because of the pragmatic nature of the trial, exclu-
sion criteria were limited. Only patients with borderline 
ovarian tumors, those who were receiving palliative care, 
and those who were unable to complete a Dutch ques-
tionnaire were excluded from participation.20 The cur-
rent analysis includes only those patients who completed 
the questionnaire assessing information coping style at 
12 months after initial treatment (Supporting Table 1). 
Primary effects of SCPs on patient-reported outcomes in 
women with endometrial7 and ovarian8 cancer have been 
described elsewhere.
Randomization and Blinding
Randomization was performed, using a table of random 
numbers, by an independent researcher who was blinded 
to the identity of the hospitals. Patients, but not oncology 
providers or researchers who assessed the outcomes, were 
blinded to trial assignment.20
SCP Care Versus Usual Care
In the hospitals that provided usual care, standard care 
was delivered in accordance with Dutch oncology guide-
lines (www.oncoline.nl, accessed October 30, 2018). In 
the hospitals that provided SCP care, all oncology pro-
viders (gynecologists/gynecologic oncologists and oncol-
ogy nurses) were instructed to provide an SCP to patients 
during the consultation at which the results of histopa-
thology and the (adjuvant) treatment plan were discussed 
(ie, 7-14 days after surgery). An updated version of the 
SCP optionally could be discussed in a follow-up con-
sultation. Providers received practical guidelines on the 
components of the SCP that minimally should be dis-
cussed with each patient during the consultation. The 
SCP was based on the Dutch translation of the National 
Academy of Medicine (NAM) SCP template,1 adjusted 
to the local situation.20 Texts of the SCP were based on 
pilot-tested patient education material from the Dutch 
Cancer Society. In addition, the SCP was pilot-tested 
on patients with low/intermediate educational levels to 
ensure that the SCP was understandable. The SCP con-
tained a treatment summary and a follow-up care plan, 
including detailed information on the short-term and 
long-term effects of the treatments received, the effects 
on social and sexual life, possible signs of recurrence 
and secondary tumors, and information on rehabilita-
tion, psychosocial support, and supportive care services. 
Original Article
790 Cancer  March 1, 2019
Details about the intervention20 and implementation21 
have been described elsewhere.
Measures
Age, socioeconomic status (SES), and clinical data were 
obtained from the Netherlands Cancer Registry.22 SES 
was based on the postal code of the patient’s area of area 
of residence23 and was categorized into low, medium, 
or high. Additional sociodemographic information was 
assessed in the first questionnaire. Marital status (mar-
ried/living together vs divorced/widowed/never married) 
and employment status (having a paid job vs not having 
a paid job) were dichotomized. Comorbidity was as-
sessed using the adapted Self-Administered Comorbidity 
Questionnaire and was categorized into no comorbidi-
ties, 1 comorbidity, or >1 comorbidity.24 Disease-related 
internet use and receipt of an SCP (“Did you receive a 
survivorship care plan?”) were treated as dichotomous 
measures.
Information coping style was assessed using the 
shortened version of the Threatening Medical Situations 
Inventory,25 which consists of 2 hypothetical descrip-
tions of threatening medical situations. The internal 
consistency of the monitoring (Cronbach α = .79) and 
blunting (Cronbach α = .73) subscales were good, and 
test-retest reliability has been established as sufficient 
for both scales (Pearson correlation, 0.64-0.83).25 A sum 
score was calculated by subtracting the blunting subscale 
score from the monitoring subscale score, as previously 
described.15 Individuals with sum scores below or equal 
to the median were categorized as monitors, and indi-
viduals with scores above the median were categorized 
as blunters.
Outcome scales were assessed in each questionnaire. 
Information provision was measured with the 25-item 
European Organization for Research and Treatment 
Quality-of-Life Group Information Questionnaire 
(EORTC-QLQINFO25),26 which has 4 multi-item 
subscales (information about the disease, medical tests, 
treatment, and other care services) and 4 single-item 
scales (information about different places of care, things 
you can do to help yourself get well, satisfaction with 
the information, and helpfulness of the information). 
Internal consistency of the scales was good in our sam-
ple (Cronbach α, 0.75-0.90). Previously, test-retest re-
liability (intraclass correlation [ICC], 0.71-0.91) was 
established as good.26 Satisfaction with care was assessed 
using the 32-item EORTC-QLQ Inpatient Satisfaction 
Questionnaire (EORTC-QLQINPATSAT32), which 
was adjusted to make the questionnaire appropriate for 
use during survivorship care27 using 2 multi-item scales 
(physician’s interpersonal skills and nurses’ interpersonal 
skills) and 2 singe-item scales (exchange of information 
between caregivers and general satisfaction with care). 
Internal consistency of the scales was good in our sample 
(Cronbach α, 0.93-0.94). Previously, test-retest reliabil-
ity (ICC, 0.66-0.85) was established as good.27 Illness 
perception was assessed using the Brief Illness Perception 
Questionnaire,28 which includes 8 single-item scales. 
Test-retest reliability (Pearson correlation, 0.42-0.75) was 
fair to good.28 Health care use was assessed according to 
the number of visits to a medical specialist or primary 
care physician in relation to cancer in the past 6 months.
Statistical Analysis
Statistical analyses were conducted using SAS version 9.4. 
(SAS Institute Inc, Cary, NC). Differences in character-
istics between patients who were included in the analyses 
and those who were lost to follow-up, both between trial 
arms and between patients with monitoring and blunting 
coping styles, were compared using t tests for normally 
distributed continuous variables, Mann-Whitney U tests 
for non-normally distributed variables, and chi-square 
tests for categorical variables.
Linear, multilevel regression analysis was performed 
to assess the moderating effect of information coping style 
on the impact of SCPs on patient-reported outcomes. A 
random intercept on the patient level was included in the 
model to adjust for intradependency between repeated 
measures.29 Random intercepts on the hospital level (ICC 
< 0.16) and random slopes on the patient level (ICC < 
0.14) were not included, because they did not improve the 
models.29 To assess the moderating effect of information 
coping style, an interaction term of information coping 
style and trial arm, with all a priori-selected covariates 
(ie, cancer type, age, time since diagnosis, marital status, 
SES, employment status, comorbidities, disease stage, 
and treatment) was added to the model. Dependent vari-
ables were the information provision and care, illness per-
ceptions, and health care use scales. For outcome scales 
in which the interaction term of coping style and trial 
arm was significant, the analyses were stratified by infor-
mation coping style. For all analyses, patients in the SCP 
care arm were compared with all patients in the usual care 
arm (intention-to-treat analysis). In addition, per-proto-
col analyses were conducted to compare patients in the 
SCP care arm who reported having received an SCP ver-
sus all patients in the usual care arm, because no SCPs 
were provided by the hospitals to patients in the usual 
care arm. Interactions with cancer type were assessed by 
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using a 3-way interaction of cancer type, coping style, 
and trial arm. Prior analyses revealed a moderating effect 
of disease-related internet use on the outcome scales.12 
Therefore, we also assessed whether there was a 3-way 
interaction between disease-related internet use, informa-
tion coping style, and trial arm on any of the outcome 
scales when adjusted for covariates.
RESULTS
In total, 221 patients with endometrial cancer and 174 
with ovarian cancer participated in the trial. Patients with 
endometrial cancer who did not participate in the trial 
were older and had higher stage cancers, as previously 
described.7,8 Furthermore, patients who had endometrial 
cancer in the SCP care arm completed the questionnaires 
later after diagnosis compared with those who had endo-
metrial cancer in the usual care arm.7 Among patients with 
ovarian cancer, women in the SCP care arm had more co-
morbidities compared with those in the usual care arm.8
The current analysis included 131 patients (59%) 
with endometrial cancer and 95 patients (55%) with 
ovarian cancer who completed the questionnaires 
at 12 months after treatment (Supporting Table 1). 
Compared with the patients who were lost to follow-up, 
patients who were included in the current analysis were 
younger, and those with endometrial cancer more often 
had a partner, had higher SES, had lower cancer stage, 
and received surgery, and they less often received che-
motherapy (Table 1). Patients who had a monitoring 
coping style more often had a partner and used the 
internet to look up medical information compared 
with those who had a blunting coping style (Table 2). 
Additional analyses stratified by cancer type demon-
strated that patients with ovarian cancer who had higher 
stage cancers more often had a monitoring coping style 
(P < .01). The monitoring and blunting groups were not 
of equal size, because 19 patients had median scores on 
the Threatening Medical Situations Inventory.
TABLE 1. Baseline Characteristics of Participants Lost to Follow-Up Versus Those Included in the Analyses 
Stratified by Cancer Type: Univariate Analysesa
Characteristic
Endometrial Cancer: No. of Participants (%) Ovarian Cancer: No. of Participants (%)
Included in 
Analyses, N = 131
Lost to Follow-Up, 
N = 90 P
Included in 
Analyses, N = 94
Lost to Follow-Up, 
N = 81 P
Age at first question-
naire: Mean ± SD, y
65.9 ± 8.7 71.3 ± 8.4 < .01a 61.9 ± 9.3 65.9 ± 12.7 < .01a
SESb
High 55 (42) 18 (20) < .01a 39 (41) 29 (36) .85
Intermediate 49 (37) 42 (47) 37 (39) 37 (46)
Low 19 (15) 24 (27) 17 (55) 14 (17)
Institutionalized/
unknown
8 (6) 6 (7) 1 (1) 1 (1)
Marital statusc
Partner 106 (81) 55 (61) < .01a 74 (79) 57 (70) .20
No partner 25 (19) 35 (39) 20 (21) 24 (30)
Employed
Yes 24 (18) 13 (14) .34 33 (35) 18 (22) .06
No 98 (75) 66 (73) 61 (65) 63 (78)
Time from diagnosis: 
Median [IQR], mo
3.0 [1.8] 3.0 [1.6] .62 2.4 [2.4] 2.8 (2.5) .20
FIGO stage
I 122 (93) 69 (77) < .01a 31 (33) 21 (26) .57
II 3 (2) 4 (4) 10 (11) 6 (8)
III 5 (4) 13 (14) 39 (41) 37 (46)
IV 1 (1) 4 (4) 14 (15) 16 (20)
Treatment
Surgery 131 (100) 86 (97) .03a 88 (96) 71 (88) .054
Chemotherapy 2 (2) 13 (14) < .01a 71 (75) 64 (79) .58
Radiotherapy 42 (32) 33 (37) .48
Comorbidity
None 24 (18) 14 (16) .17 29 (31) 27 (33) .33
1 29 (22) 26 (29) 33 (35) 20 (25)
≥2 77 (59) 46 (51) 31 (33) 34 (42)
Abbreviations: FIGO, International Federation of Gynecology and Obstetrics; IQR, interquartile range; SD, standard deviation; SES, socioeconomic status.
aThis P value indicates a statistically significant difference.
bSES was based on the postal code of the patient’s residence.
cMarital status included partner (married/living together) and no partner (divorced/widowed/never married). Values may not always add up to 100%, because 
percentages have been rounded off to whole numbers.
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There was no significant interaction between can-
cer type and information coping style for any of the 
outcome scales. Among patients with endometrial can-
cer and those with ovarian cancer, information coping 
style significantly moderated the impact of SCPs on 
the outcomes scales, as illustrated in Table 3. No mod-
erating effect of information coping style on the impact 
of SCPs was observed on satisfaction with information 
about medical tests and other services, the interper-
sonal skills of the physician, exchange of information 
between caregivers, perceptions about the timeline, 
personal control, treatment control, identity, emotions 
and understanding of the disease, and cancer-related 
contact with the medical specialist and primary care 
physician. Crude means at all time points stratified by 
information coping style and trial arm are illustrated in 
Figure 1. Overall, patients who had a monitoring cop-
ing style were more satisfied with information and care 
and had less threatening illness perceptions compared 
with those who had a blunting coping style. Stratified, 
multilevel linear regression analyses subsequently re-
vealed that, among patients who had a monitoring 
coping style, compared with patients in the usual care 
arm, those in the SCP care arm reported higher receipt 
of information about treatments (β = 8.9; 95% con-
fidence interval [CI], 2.2-15.5; P < .01), information 
about things to do to get well (β = 11.6; 95% CI, 3.3-
19.9; P < .01), satisfaction with information received (β 
= 7.7; 95% CI, 0.3-15.1; P = .04), perceived helpfulness 
of the information received (β = 8.4; 95% CI, 1.4-15.3; 
P = .02), and higher general satisfaction with care (β = 
6.2; 95% CI, 0.7; 11.8; P = .03). Among patients who 
had a blunting coping style, compared with patients in 
the usual care arm, those in the SCP care arm reported 
a higher impact of the disease on life (β = 0.9; 95% CI, 
0.2-1.7; P = .02) and more concerns about the illness (β 
= 1.1; 95% CI, 0.3-1.9; P = .01) (Table 3). In addition, 
a significant 3-way interaction was observed between 
TABLE 2. Characteristics of Patients Included in the Analyses Stratified by Information Coping Style: 
Univariate Analyses
Characteristic
No. of Patients (%)a
PMonitoring Coping Style, N = 123 Blunting Coping Style, N = 102
Age at first questionnaire: Mean ± SD, y 63.3 (9.1) 65.4 (9.2) .10
SESb
High 54 (44) 41 (40) .30
Intermediate 46 (37) 40 (39)
Low 16 (13) 20 (19)
Institutionalized/unknown 7 (6) 2 (2)
Marital statusc
Partner 108 (88) 72 (70) < .01d
No partner 15 (12) 31 (30)
Employed
Yes 33 (28) 24 (24) .46
No 83 (72) 76 (76)
Cancer type
Endometrial 74 (60) 57 (55) .46
Ovarian 49 (40) 46 (45)
Time from diagnosis: Median [IQR], mo 3.0 [2.0] 2.8 [2.2] .77
FIGO stage
I 80 (65) 74 (72) .06
II 8 (7) 5 (5)
III 22 (18) 22 (21)
IV 13 (11) 2 (1)
Treatment
Surgery 120 (98) 100 (98) .86
Chemotherapy 42 (34) 31 (30) .52
Radiotherapy 15 (17) 27 (19) .73
Comorbidity
None 31 (26) 22 (21) .86
1 32 (26) 30 (29)
≥2 58 (48) 50 (49)
Disease-related internet use
Yes 67 (54) 36 (35) < .01d
No 56 (46) 66 (65)
Abbreviations: FIGO, International Federation of Gynecology and Obstetrics; IQR, interquartile range; SD, standard deviation; SES, socioeconomic status.
aNote that the monitoring and blunting groups are not of equal size, because 19 patients had a median score on the Threatening Medical Situations Inventory.
bSES was based on the postal code of the patient’s residence.
cMarital status included partner (married/living together) and no partner (divorced/widowed/never married). Values may not always add up to 100%, because 
percentages have been rounded off to whole numbers.
dThis P value indicates a statistically significant difference.
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TABLE 3. Effects of the Intervention on Patients With Endometrial and Ovarian Cancer Stratified by 
Information Coping Style: Intention-to-Treat Analyses of the Overall Effects at All Time Points Combined 
(0, 6, 12, and 24 Months)a
Monitoring Coping Style 
(NPatients = 123, NObservations = 453)
b
Blunting Coping Style 
(NPatients = 201, NObservations = 347)
b
Mean ± SD Mean ± SD
Measurec SCP Care Usual Care β (95% CI) SCP Care Usual Care β (95% CI)
Satisfaction with information provision
Disease 64.4 ± 20 58.9 ± 22 3.5 (−2.7, 9.7) 60.7 ± 19 63.5 ± 23 −4.8 (−12.5, 2.8)
Treatment 57.0 ± 24 47.3 ± 24 8.9 (2.2-15.5)d,e 50.2 ± 24 54.7 ± 27 −3.5 (−12.5, 5.6)
Things to do 44.5 ± 29 34.4 ± 30 11.6 (3.3-19.9)d,e 40.4 ± 32 42.0 ± 36 −3.3 (−14.5, 8.0)
Satisfaction 73.9 ± 23 63.9 ± 24 7.7 (0.3-15.1)d,f 74.5 ± 21 75.1 ± 25 −1.4 (−9.5, 6.7)
Helpfulness 76.5 ± 24 66.8 ± 22 8.4 (1.4-15.3)d,f 75.0 ± 21 75.4 ± 24 −1.2 (−9.1, 6.8)
Satisfaction with care
Nurse interpersonal skills 75.0 ± 19 72.5 ± 19 2.9 (−4.3, 10.2) 72.9 ± 18 79.9 ± 20 −6.5 (−13.2, 0.3)
General satisfaction with care 74.5 ± 18 69.2 ± 19 6.2 (0.7-11.8)d,f 74.5 ± 17 76.1 ± 20 −1.7 (−7.2, 2.9)
Illness perceptions
How much illness affects life 5.4 ± 2.7 5.2 ± 2.8 0.0 (−0.7, 0.8) 5.0 ± 2.6 4.5 ± 2.6 0.9 (0.2-1.7)d,f
How concerned about illness 5.5 ± 2.7 5.4 ± 2.9 0.2 (−0.6, 1.1) 5.4 ± 2.4 4.2 ± 2.6 1.1 (0.3-1.9)d,f
Abbreviations: CI, confidence interval; SCP, survivorship care plan; SD, standard deviation.
aNote that linear, multilevel regression analyses stratified by coping style were performed and were adjusted for covariates. Only the scales on which the in-
teraction term was significant are included in the table. Analyses report the results of the main effect of the intervention after diagnosis and after 6, 12, and 24 
months stratified by coping style.
bCrude mean and SD values are reported for SCP care and usual care. Unstandardized β values and CIs are reported for SCP care (with usual care as the refer-
ence group).
cScores on the 25-item European Organization for Research and Treatment Quality-of-Life Group (EORTC-QLQ) Information Questionnaire (measuring satis-
faction with information provision) and the 32-item EORTC-QOL In-Patient Satisfaction Questionnaire (measuring satisfaction with care) scales range from 0 
to 100, with higher scores reflecting better perceived information and care received. Scores on the Brief Illness Perception Questionnaire (measuring illness 
perceptions) range from 1 to 10, with higher scores indicating more endorsement of that item.
dThese values indicate that the main effect of the intervention was significant in stratified analysis.
eP < .01.
fP < .05.
Figure 1. The mean values of trial outcomes stratified by trial arm and information coping style at 0, 6, 12, and 24 months 
are illustrated. Note that crude means are reported. Monitors are patients who have an information-seeking coping style, and 
blunters are those who have an information-avoiding coping style. Only outcomes that differed significantly between trial arms in 
either monitors or blunters are included. An asterisk indicates P < .05 in the overall intention-to-treat analysis. Detailed statistics 
are provided in Table 3. SCP indicates survivorship care plan.
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disease-related internet use and information coping 
style on the helpfulness scale: patients in the SCP care 
arm with a monitoring coping style who did not use 
the internet for medical information reported higher 
helpfulness of the information received (β = 14.7; 95% 
CI, 3.4-25.9; P = .01), whereas those with a monitoring 
coping style who did use the internet for medical infor-
mation did not report higher helpfulness (β = 6.8; 95% 
CI, −2.6, 16.2; P = .15).
In a per-protocol analysis comparing patients in the 
SCP care arm who reported receipt of an SCP  (endometrial 
cancer, N = 60 patients [87%]; ovarian cancer, 
N = 24 patients [75%]) with all patients in the usual care 
arm (endometrial cancer, N = 62 patients; ovarian cancer, 
N = 63 patients) produced similar results.
DISCUSSION
The current study demonstrates that information coping 
style moderates the impact of SCPs on patient-reported 
outcomes among patients with gynecologic cancers dur-
ing 2 years of follow-up. SCPs appear to improve satis-
faction with information and care among patients who 
desire information about their disease (ie, monitors), 
whereas SCPs appears to increase worry and perceived 
consequences of the cancer among patients who avoid 
medical information (ie, blunters), suggesting a need for 
the tailored delivery of SCPs. No moderating effect of 
coping style was observed on the use of health care.
In line with the literature regarding information 
coping styles,17,30 monitors generally were satisfied less 
with information and care compared with blunters, 
suggesting that there is room for improvement among 
patients with a monitoring coping style. Consistent 
with our hypothesis, SCPs appear to meet the high in-
formation needs among monitors by substantially in-
creasing satisfaction in this subgroup (up to 12 points 
on a scale from 0 to 100), resulting in satisfaction levels 
similar to those observed among blunters. The other 
side of the coin is that blunters, who generally have 
lower baseline levels of distress,31 appear to experience 
increased worry and a higher impact of the disease on 
life when they receive an SCP. This is consistent with 
a trial among gynecologic patients demonstrating that 
stress reduction among blunters is most optimal when 
they receive minimal information, as opposed to exces-
sive information.19 Excessive information may increase 
arousal among blunters, because they are confronted 
with detailed information about a health threat they 
initially did not worry about.18,25 In a sample of gyneco-
logic patients with a blunting coping style, this resulted 
in self-reported tension, depression, and physical dis-
comfort before and during a diagnostic procedure.19 
In contrast, an information brochure for patients who 
were undergoing gastrointestinal coloscopy was benefi-
cial in reducing anxiety among those who had a moni-
toring coping style.18 Hence, our results are in line with 
previous health information intervention studies.
In addition, we observed that monitors more often 
used the internet to look up information about their dis-
ease compared with blunters, whereas SCPs appeared 
most helpful for monitors who did not do so. These find-
ings suggest that SCPs are most valuable for patients who 
desire information about their disease but do not have 
access to resources like the internet. This is in line with 
earlier findings from our trial, in which patients with en-
dometrial cancer who did not use the internet benefited 
from SCPs.12 It is noteworthy that prior analyses of our 
trial demonstrated that more threatening illness percep-
tions because of the SCP (ie, more worry and experienced 
symptoms and lower trust in the treatment) resulted in 
worse long-term health-related quality of life and more 
anxiety.32 Therefore, we should be aware of the potential 
harmful effects of SCPs in patients with a blunting cop-
ing style. Yet appropriate counseling accompanied with 
the SCP may reduce the harmful effects on health-related 
quality of life.33
It also is worth noting that, in a previous report on 
our trial, SCPs increased cancer-related contact with the 
primary care physician among patients with endometrial 
cancer in the first year after treatment,7 which appeared 
to be related to anxiety.34 Therefore, we hypothesized 
that patients with an information coping style, who gen-
erally have higher levels of distress, would be encouraged 
more often to contact their care providers for additional 
questions and concerns with regard to the SCP. However, 
we did not observe a moderating effect of information 
coping style on health care use. Perhaps our findings 
were diluted by our overall analyses of all time points 
combined. Unfortunately, the numbers were too small to 
conduct analyses separately for each time point.
A limitation of this study includes the selective sam-
ple of patients who participated in our trial until at least 
12 months after initial treatment and who completed 
the questionnaires included in the this analysis. Patients 
who were older and had higher stage cancers more often 
were lost to follow-up, which may be because of death or 
ill-health. Consequently, the number of patients in the 
current study was too small to conduct stratified analyses 
separately for those with endometrial cancer and ovarian 
cancer, because our trial was powered on an analyses of 
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patients who were included from baseline (n = 75 per trial 
arm per cancer type). Although there were no significant 
interactions with cancer type, the magnitude of the mod-
erating effect of coping style may differ between cancer 
types. Furthermore, although patients were told that they 
participated in an observational study, and response rates 
were high, patients with a blunting coping style may be 
under-represented in our trial, because they do not like 
to be reminded of their cancer.31 This may have resulted 
in an underestimation of the potential harmful effects 
of SCPs among blunters. Furthermore, because of our 
pragmatic approach, not all patients in the intervention 
arm reported receipt of an SCP, resulting in an underes-
timation of the impact when all patients would receive an 
SCP. Also, unlike most trials, SCPs were provided after 
initial treatment while some patients were still receiving 
adjuvant treatment. This may have enlarged the detri-
mental impact on illness perceptions among blunters, 
because information may have been provided too early.
Another limitation is that information coping 
style was assessed at 12 months after initial treatment. 
Although it has been demonstrated that information 
coping style is fairly stable over a 1-month period,25,35 
we observed that patients who had ovarian cancer with 
higher stage cancer more often had a monitoring coping 
style. Although information coping style has not previ-
ously been associated with disease-related characteris-
tics,36 our finding suggest that information coping style 
may be modified by the experience of a cancer diagnosis, 
and possibly even by the receipt of an SCP. However, 
the distribution of monitors and blunters did not dif-
fer between trial arms, indicating that this probably did 
not affect our results, although it does suggest that re-
peated assessments of information coping style may be 
needed to provide appropriate information when needs 
have been changed. Furthermore, there is no consensus 
on whether the outcomes in our analysis (eg, patient 
satisfaction) are the most relevant for evaluating SCPs. 
Future studies may need to focus on more proximal out-
comes, such as the understanding of survivorship care 
issues, care provider roles, self-management, and sense 
of control.3,37
It is important to note that the SCPs provided in our 
trial were extensive documents (ie, up to 25 pages) con-
taining detailed information about potential long-term 
and late effects and explicit information about the chance 
of recurrence.20 The impact of such a voluminous SCP 
may be much greater compared with treatment summa-
ries or brief SCPs comprising only a couple of pages of in-
formation.38 However, these extensive SCPs principally 
may meet the high information needs of monitors, 
whereas brief SCPs may be more beneficial for blunters. 
The heterogeneity of information needs among cancer 
survivors also may explain why neither brief nor extensive 
SCPs appear to be beneficial for patient populations as a 
whole in current SCP trials.3 Hence, either withholding 
information or providing information to all patients uni-
formly would not achieve patient satisfaction. Rather, we 
may need to develop distinct templates of SCPs that are 
tailored to patients’ information needs, which not only 
would improve survivors’ outcomes but also may contrib-
ute to the more efficient distribution of the limited re-
sources in survivorship care. Hence, we believe that risk 
stratification according to information and care needs, 
similar to that applied in individualized follow-up,39 is 
needed to accomplish the effective and efficient provision 
of survivorship information. Determining whether SCPs 
should be individualized according to information dose 
only (ie, extensive vs brief SCPs) or also on content (ie, 
focus on physical vs psychological aspects)40 will require 
further research. Possibly, a simple set of screening ques-
tions to determine information needs may be sufficient to 
use tailored SCPs in clinical practice, although repeated 
assessments may be required, because needs may change 
over time. This may be feasible particularly for a setting 
in which information is provided online. Furthermore, 
our findings may apply to other types of health infor-
mation provision, suggesting that careful evaluation of 
the effects of various information provision interventions 
across coping styles is needed before implementation in 
clinical practice.
CONCLUSION
Although SCPs may not be helpful for all cancer survi-
vors,7,8 they appear to be valuable for some survivor sub-
groups. The current study demonstrates that SCPs may 
be beneficial for patients who desire detailed information 
about their cancer, whereas they may be less beneficial 
and perhaps even harmful for patients who prefer to 
avoid medical information. Our results emphasize the 
need to individualize the delivery of SCPs according to 
patients’ information needs.
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